Several participants reported symptom relief and reduced reliance on pain medication.
Photo | © adobestock.com/smolaw11
A recently published study examined how cannabinoids can be used as a therapeutic treatment for the chronic inflammatory disease, endometriosis (1). As explained in the study’s introduction, research suggests that the pathophysiology of the endocannabinoid system and endometriosis are connected. Researchers aimed to gauge how often cannabis was used to alleviate pain from endometriosis and if it helped reduce pain medication use.
Results from the cross-sectional survey, “Cannabis use in endometriosis: the patients have their say—an online survey for German-speaking countries,” were published in the Archives of Obstetrics and Gynecology in August 2024.
The online survey was distributed via a direct link and also to endometriosis support groups through social media – the link was active from August to December 2022. Researchers analyzed responses from 912 of the participants, who were ages 18 and older and were living in Germany, Austria, and Switzerland. Cannabis use was illegal in the countries at the time the survey was conducted. As stated in the study, notable results included:
Researchers noted that previous data and studies on cannabis as a treatment for endometriosis is limited and does not support its use, yet surveys from various countries have revealed the self-managed use of cannabinoids for pain reduction. “Self-management strategies are commonly used in several parts of Europe, with cannabis being described as the most effective method for managing endometriosis-related symptoms,” the researchers explained. “The study indicates that there is a significant interest and demand for additional therapeutic options, and cannabis can potentially become an important part of a multimodal therapy approach for treating endometriosis.”
Most of the participants indicated that they would be interested in using a medical cannabis product (80% of respondents were interested in a CBD product and 66% for a THC product) to treat endometriosis symptoms, especially if prescribed by a physician, though prescribing cannabis has previously been proven to be a challenge in German-speaking countries.
Reference
Ep 26: Innovations in Drying and Curing to Protect Flower Quality
May 27th 2025In this latest installment of Noid Knowledge, we are joined by Dr. Allison Justice, Founder and CEO of the Hemp Mine, and David Sandelman COO, CTO & Co-Founder of Cannatrol. Here, Allison and David discuss innovations in cannabis drying and curing, focusing on the Cannatrol technology which controls vapor pressure, preserving trichome integrity, and flower quality. Additionally, Allison shares how the Cannabis Research Center and Coalition (CRC) is transition to an open-source model to support cultivators, researchers, and home growers.
Ep 25: Cannabis Quality Differentiation Beyond Cannabinoid Content
February 28th 2025In this latest installment of Noid Knowledge we are joined by Julie Kowalski, a leading mind in analytical chemistry and cannabis testing. Julie has arranged a very compelling symposium for Pittcon entitled Cannabis Aroma: Advances and Challenges in Determining and Commercializing Cannabis Product Quality Attributes. It is taking place on Wednesday, March 5, 2025, starting at 9:30 AM in room 209. The session features top notch speakers, including several previous guests of this show, and yours truly, discussing the next generation of quality assessment in cannabis.